These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10842925)

  • 1. [Pharmaceutical applications of the zeta potential--use in characterization of colloidal drug carriers].
    Le Roy Boehm AL; Fessi H
    J Pharm Belg; 2000; 55(2):40-8. PubMed ID: 10842925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of submicron systems via optical methods.
    Haskell RJ
    J Pharm Sci; 1998 Feb; 87(2):125-9. PubMed ID: 9519143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration.
    Müller-Goymann CC
    Eur J Pharm Biopharm; 2004 Sep; 58(2):343-56. PubMed ID: 15296960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The formalism of fractal aggregation phenomena of colloidal drug delivery systems.
    Pippa N; Demetzos C; Danezis E
    J Liposome Res; 2012 Mar; 22(1):55-61. PubMed ID: 21774618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Encapsulation, Protection, and Oral Delivery of Bioactive Proteins and Peptides using Colloidal Systems.
    Perry SL; McClements DJ
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32150848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
    Simovic S; Barnes TJ; Tan A; Prestidge CA
    Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation, protection, and release of hydrophilic active components: potential and limitations of colloidal delivery systems.
    McClements DJ
    Adv Colloid Interface Sci; 2015 May; 219():27-53. PubMed ID: 25747522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colloidal soft matter as drug delivery system.
    Bonacucina G; Cespi M; Misici-Falzi M; Palmieri GF
    J Pharm Sci; 2009 Jan; 98(1):1-42. PubMed ID: 18452176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization.
    Benita S; Levy MY
    J Pharm Sci; 1993 Nov; 82(11):1069-79. PubMed ID: 8289116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems.
    Kuntsche J; Horst JC; Bunjes H
    Int J Pharm; 2011 Sep; 417(1-2):120-37. PubMed ID: 21310225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Submicron emulsions as drug carriers. Studies on destabilization potential of various drugs.
    Sznitowska M; Janicki S; Dabrowska E; Zurowska-Pryczkowska K
    Eur J Pharm Sci; 2001 Jan; 12(3):175-9. PubMed ID: 11113636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I.
    Abdel-Mottaleb MM; Lamprecht A
    Drug Dev Ind Pharm; 2011 Feb; 37(2):178-84. PubMed ID: 21073322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow.
    Moghimi SM; Illum L; Davis SS
    Crit Rev Ther Drug Carrier Syst; 1990; 7(3):187-209. PubMed ID: 2073686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization.
    Schwarz C; Mehnert W
    J Microencapsul; 1999; 16(2):205-13. PubMed ID: 10080114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.
    Babaei S; Ghanbarzadeh S; Adib ZM; Kouhsoltani M; Davaran S; Hamishehkar H
    Pharmazie; 2016 May; 71(5):247-51. PubMed ID: 27348967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.
    Calvo P; Vila-Jato JL; Alonso MJ
    J Pharm Sci; 1996 May; 85(5):530-6. PubMed ID: 8742946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical aspects of using liposomes as delivery vehicles.
    Ulrich AS
    Biosci Rep; 2002 Apr; 22(2):129-50. PubMed ID: 12428898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid vehicles for the parenteral administration of drugs (2): liposomes].
    Bermejo Vicedo T; Carrasco Real JM; Hidalgo Correas FJ
    Nutr Hosp; 1996; 11(2):69-81. PubMed ID: 8695713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocapsules prepared via nanoprecipitation and emulsification-diffusion methods: comparative study.
    Mora-Huertas CE; Garrigues O; Fessi H; Elaissari A
    Eur J Pharm Biopharm; 2012 Jan; 80(1):235-9. PubMed ID: 21983604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker.
    Hathout RM; Elshafeey AH
    Eur J Pharm Biopharm; 2012 Oct; 82(2):230-40. PubMed ID: 22820090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.